Main Page Article Search E-Lerts™ Newsletter: Current E-Lerts™ Newsletter Archives E-Lerts™ Newsletter Recipes Archives Defeat Diabetes® E-Lerts™ Newsletter Subscribe Defeat Diabetes ® News by Daniel H. Rasolt Books You Can Use™ Subscribe to Defeat Diabetes Foundation Mailings
About Diabetes Body Care Children Complications Defeat Diabetes Foundation Drugs    » ACE Inhibitor    » Actos    » Alternative Medicine    » Aspirin    » Avandia    » Byetta    » Drugs    » Exenatide    » Glargine    » Glucophage    » Insulin    » Januvia    » Lantus    » Liraglutide    » Metformin    » Recall    » Research    » Rosiglitazone    » Self-Management    » Statins    » Sulfonylureas    » Victoza Elderly E-Lerts™ Governments & Organizations Health & Fitness Insulin MADDCAP™ Mr. Diabetes® Nutrition Obesity Other Diseases Pregnancy Research Risks Self-Management Supplements Type 1 Warning Signs

 

 

 

     

Drugs » Drugs

Search our News Articles Archives for diabetes and health news. Search by word or phrase.  The latest article will appear first.

Search For:  

Search in all categories / subcategories
Search in current category / subcategory

Naltrexone/Bupropion Combo Increases Women's Weight Loss Posted: Monday, May 23, 2011

Two phase 3 studies have found that a combination of naltrexone SR/bupropion SR can produce significant weight loss in overweight and obese women, regardless of menopausal status.

FDA Approves New DPP-IV Inhibitor: Tradjenta (Linagliptin) Posted: Sunday, May 08, 2011

A new prescription medication Tradjenta (linagliptin) has gained FDA approval for the treatment of adult Type 2 diabetes. Tradjenta will compete with two other drugs in the same family, Onglyza and Januvia.

New Guidelines on Best Treatments for Diabetic Nerve Pain Posted: Saturday, April 23, 2011

The American Academy of Neurology has issued a new guideline on the most effective treatments for diabetic nerve pain.

Some Diabetes Drugs Are Better than Others According to New Study Posted: Sunday, April 17, 2011

New research suggests that several commonly prescribed drugs for Type 2 diabetes may not be as effective at preventing death and cardiovascular diseases, such as heart attacks and stroke, as the oral anti-diabetic drug, metformin.

New Choices for Neuropathy Treatment Posted: Sunday, April 10, 2011

Researchers suggested that, switching to duloxetine (Cymbalta) or pregabalin (Lyrica) can produce pain relief for patients with diabetic neuropathy who stop responding to gabapentin (Neurontin).

Potential New Non-Insulin Treatment for Type 1 Diabetes Posted: Tuesday, April 05, 2011

Researchers have discovered a hormone pathway that potentially could lead to new ways of treating Type 1 diabetes independent of insulin.

Blood Pressure Drug Delays Kidney Disease in Diabetes Patients Posted: Sunday, March 20, 2011

The drug pressure-reducing medication olmesartan, brand name Benicar, could increase the time before any kidney problems were evident by 23 percent. But experts are concerned about higher deaths from heart problems.

Study Finds Three Times-a-Week Insulin Improves Glucose Levels Posted: Sunday, March 20, 2011

An alternate form of insulin that is longer lasting may be approved in upcoming years.

Carb Counting vs. Glycemic Load to Determine Insulin Bolus? Posted: Sunday, March 20, 2011

How many carbs you eat might be less important for your blood sugar than your food's glycemic load.

Anti-VEGF Drug Reverses Diabetic Vision Loss Posted: Sunday, March 20, 2011

Patients headed toward blindness because of diabetic macular edema showed substantial gains in visual acuity after two years of treatment with the angiogenesis inhibitor drug ranibizumab (Lucentis), its manufacturer said.

 

 

 

 

 

 Costa Rica Travel Corp. will donate a portion of the proceeds to and is a sponsor of Defeat Diabetes Foundation.